Topoisomerase activities in undifferentiated acute myeloblastic leukemias and monocytic differentiated leukemias.
Gieseler
F
F
Medizinische Poliklinik, University of Würzburg, Germany.
Glasmacher
A
A
Kämpfe
D
D
Zernak
C
C
Valsamas
S
S
Kunze
J
J
Clark
M
M
D001853:Bone Marrow / Q000201:enzymology / Q000473:pathology; D004250:DNA Topoisomerases, Type II / Q000097:blood / Q000378:metabolism*; D003630:Daunorubicin / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D015255:Idarubicin / Q000494:pharmacology; D007948:Leukemia, Monocytic, Acute / Q000097:blood / Q000201:enzymology* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000201:enzymology* / Q000473:pathology; D059005:Topoisomerase II Inhibitors
D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D004250:DNA Topoisomerases, Type II; D015255:Idarubicin; D003630:Daunorubicin